NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO) in a research note issued to investors on Friday morning. The firm issued a sell rating on the medical device company’s stock.

NeuroMetrix Price Performance

Shares of NASDAQ NURO opened at $4.70 on Friday. NeuroMetrix has a 1 year low of $2.70 and a 1 year high of $11.52. The firm has a 50-day moving average of $3.92 and a 200 day moving average of $3.76. The stock has a market cap of $9.35 million, a P/E ratio of -0.75 and a beta of 2.26.

NeuroMetrix (NASDAQ:NURO) last issued its earnings results on Thursday, February 22nd. The medical device company reported ($1.43) earnings per share (EPS) for the quarter. NeuroMetrix had a negative return on equity of 31.31% and a negative net margin of 110.64%. The firm had revenue of $1.32 million during the quarter.

Institutional Trading of NeuroMetrix

An institutional investor recently bought a new position in NeuroMetrix stock. Cerity Partners LLC acquired a new position in NeuroMetrix, Inc. (NASDAQ:NURO) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned approximately 2.80% of NeuroMetrix as of its most recent SEC filing. 19.40% of the stock is owned by hedge funds and other institutional investors.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.